Literature DB >> 8212579

Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef.

P Dickie1, F Ramsdell, A L Notkins, S Venkatesan.   

Abstract

The pathophysiological consequence of HIV-1 nef gene expression was investigated in transgenic mice carrying a cDNA for Nef linked to either the HIV-1 LTR or the MMTV LTR. In HIV/Nef transgenic mouse lines, nef expression was detected exclusively in the skin and a significant fraction of HIV/Nef transgenic animals (30-75%, depending on the line) spontaneously developed discrete proliferative skin lesions resembling papillomas that were often accompanied by a progressive ulceration of the epidermal cell layer. Nef protein was detected in the basal cell layer of the epidermis and was elevated in the proliferating epidermis. Epidermal cell proliferation could be induced by UV-C irradiation of HIV/Nef transgenic animals but not control mice. An increase in nef expression in the skin accompanied this proliferation. MMTV/Nef mouse lines expressed Nef RNA and protein in organs typically permissive for MMTV LTR-directed transcription but with no obvious pathological consequence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8212579     DOI: 10.1006/viro.1993.1607

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors.

Authors:  Cleve O James; Ming-Bo Huang; Mafuz Khan; Minerva Garcia-Barrio; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Characterization of Nef-CXCR4 interactions important for apoptosis induction.

Authors:  Ming-Bo Huang; Ling Ling Jin; Cleve O James; Mahfuz Khan; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease.

Authors:  Marie-Chantal Simard; Pavel Chrobak; Denis G Kay; Zaher Hanna; Serge Jothy; Paul Jolicoeur
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases.

Authors:  Edward A Acheampong; Zahida Parveen; Lois W Muthoga; Mehrnush Kalayeh; Muhammad Mukhtar; Roger J Pomerantz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.

Authors:  W Reid; M Sadowska; F Denaro; S Rao; J Foulke; N Hayes; O Jones; D Doodnauth; H Davis; A Sill; P O'Driscoll; D Huso; T Fouts; G Lewis; M Hill; R Kamin-Lewis; C Wei; P Ray; R C Gallo; M Reitz; J Bryant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

7.  HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals.

Authors:  A D Raymond; T C Campbell-Sims; M Khan; M Lang; M B Huang; V C Bond; M D Powell
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

Review 8.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 9.  Transgenic mice and squamous multistage skin carcinogenesis.

Authors:  K Brown; A Balmain
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

10.  Hallmarks of HIV-1 pathogenesis are modulated by Nef's Secretion Modification Region.

Authors:  Kateena Addae Konadu; Joseph S Anderson; Ming-Bo Huang; Syed A Ali; Michael D Powell; Francois Villinger; Vincent C Bond
Journal:  J AIDS Clin Res       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.